casemark/atm-equity-distribution-agreement
skills/legal/atm-equity-distribution-agreement/SKILL.md
Drafts a market-standard At-The-Market (ATM) Equity Distribution Agreement for public issuers conducting continuous shelf offerings under Rule 415(a)(4). Use when establishing or renewing an ATM program under an effective Form S-3, drafting a sales agent agreement, or structuring a continuous equity offering program.
$ install --global
skillsauthnpx skillsauth add casemark/skills atm-equity-distribution-agreementInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
Security Scan Results
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
3
Scanners Passed
9
Scanners in report
Clean
TrivyContainer and dependency vulnerability scanner
95%
Clean
SemgrepStatic code analysis for vulnerabilities
95%
Clean
mcp-scan (Snyk)Model Context Protocol security validation
95%
Skipped
Snyk (dep)Open source security scanning
50%
Skipped
Socket.devSupply chain security analysis
50%
Skipped
VirusTotalMulti-engine malware detection
50%
Skipped
CrowdStrikeAdvanced threat intelligence
50%
Skipped
OSV-ScannerOpen Source Vulnerability database check
50%
Skipped
OWASP Dep-Check
50%
Last scanned: May 25, 2026, 3:28 AM23.8s1 file scanned
SKILL.md
- name:
- atm-equity-distribution-agreement
- language:
- en
- description:
- Drafts a market-standard At-The-Market (ATM) Equity Distribution Agreement for public issuers conducting continuous shelf offerings under Rule 415(a)(4). Use when establishing or renewing an ATM program under an effective Form S-3, drafting a sales agent agreement, or structuring a continuous equity offering program.
ATM Equity Distribution Agreement
Generates an Equity Distribution Agreement for an ATM offering program compliant with Rule 415(a)(4), Regulation M, and applicable exchange listing rules.
Prerequisites
Collect before drafting:
- Issuer — legal name, state of incorporation, principal office
- Registration statement — Form S-3 file number, effective date, maximum aggregate offering amount
- Securities — class, par value, proposed ATM program maximum (must not exceed shelf availability)
- Agent(s) — legal name(s), FINRA registration status, commission rate (market: 2–3%)
- Exchange — principal listing market (NYSE/Nasdaq); 20%-cap shareholder approval status
- Existing arrangements — prior ATM agreements, lock-ups, co-manager arrangements
Document Structure
| Section | Key Contents | |---|---| | Parties & Recitals | Party names; shelf registration citation; Rule 415(a)(4) characterization | | Definitions | Shares, Placement Notice, Floor Price, Commission, Applicable Time, VWAP, Issuance Cap, Suspension Notice | | Agency Appointment | Non-exclusive; commercially reasonable efforts; not an underwriter; sub-agent consent | | Sale Mechanics | Placement notice process; volume caps; daily confirmations; T+2 settlement; DTC delivery | | Compensation | Commission % of gross proceeds; expense allocation; wire instructions | | Reps & Warranties | Corporate, registration/disclosure, capitalization, financial, compliance, litigation | | Issuer Covenants | Registration maintenance, reporting, notification, blackouts, due diligence access, ongoing deliverables | | Indemnification | Mutual indemnification; defense procedures; contribution (cap = commissions received) | | Conditions Precedent | Initial closing deliverables; per-placement conditions | | Termination | Mutual notice; immediate triggers; automatic events; post-termination obligations | | General Provisions | NY/DE governing law; jury waiver; notices; integration; severability; confidentiality |
Sale Mechanics
Placement Notice — Issuer delivers written notice specifying max shares, floor price, and sales period. Agent sells on commercially reasonable efforts basis and provides daily confirmations (shares sold, gross/net proceeds, VWAP).
Volume Limits — Daily cap typically ≤ 25% of average daily trading volume. Program cap must not exceed shelf availability; track against exchange listing limits.
Settlement — T+2 via DTC through issuer's transfer agent.
Mandatory Suspension Triggers:
- Issuer possesses undisclosed MNPI
- Quarterly earnings blackout
- Registration statement not effective or stop order in effect/threatened
- Exchange trading halt
Representations & Warranties
Corporate — Duly organized; full authority; agreement enforceable (subject to bankruptcy/equity carve-outs); no conflicts; no outstanding consents.
Registration & Disclosure — Registration statement effective, no stop order; compliant with Securities Act; no material misstatement/omission (10b-5 standard); Exchange Act filings current.
Capitalization — Accurate share counts; shares when issued will be validly issued, fully paid, non-assessable; no undisclosed preemptive rights; options/warrants/convertibles disclosed.
Financial — Financials present fairly per GAAP; no undisclosed MAC since most recent financials.
Compliance & Litigation — Material permits held; no undisclosed proceedings with potential MAE.
Issuer Covenants
- Maintain registration statement effectiveness; provide agent advance copies of amendments
- Furnish all Exchange Act filings and material communications
- Immediately notify agent of any event causing prospectus misstatement/omission
- Suspend sales during MNPI possession and earnings blackouts
- Provide reasonable due diligence access
- Deliver quarterly (and on request): officer's certificate (CEO + CFO), counsel opinion, negative assurance letter, auditor comfort letter
Indemnification & Contribution
- Issuer → Agent: Losses from misstatement/omission in registration statement, prospectus, or supplements (except agent-furnished information)
- Agent → Issuer: Losses from agent-furnished written information only
- Defense: Prompt notice; indemnitor may assume defense; no settlement without consent unless unconditional release with no fault admission
- Contribution: When indemnification unavailable; allocated by relative benefit and fault; agent cap = total commissions received
Conditions Precedent
Initial Closing — Executed agreement; counsel opinion; negative assurance letter; comfort letter; officer's certificate; exchange listing approval; registration statement confirmed effective.
Per-Placement — Reps true in all material respects; covenants performed; no stop order; no MAC; shares not suspended/delisted; updated opinions and comfort letters as required.
Termination
| Type | Terms | |---|---| | Mutual notice | 5–10 business days (allows pending transaction wind-down) | | Agent immediate | Trading suspension; stop order; issuer MAC; material breach; market disruption | | Automatic | All shares sold; registration expires; delisting; bankruptcy | | Post-termination | Settle pending trades; pay commissions; final reconciliation; indemnification survives |
Pitfalls & Verification
- Rule 415(a)(4): Confirm all sales qualify as at-the-market (existing trading market, not fixed price); verify block transaction provisions preserve this characterization
- Regulation M: Address agent market activity restrictions during distribution periods [VERIFY current SEC guidance]
- Exchange 20% Cap: Confirm shareholder approval status (NYSE § 312 / Nasdaq Rule 5635) [VERIFY current rule text]
- Form S-3 Eligibility: Public float ≥ $75M; Baby Shelf Rule limits issuers with float < $75M to 1/3 of float per 12 months [VERIFY]
- No Underwriter Characterization: Agent must act on commercially reasonable efforts basis throughout — avoid Securities Act § 11 underwriter liability
- Shelf Tracking: Include mechanism to track shares sold against program maximum and remaining availability
- FINRA: Confirm registered broker-dealer status; Rule 5110 filing requirements may apply [VERIFY]
- Concurrent Programs: Track aggregate issuances across all ATM and equity programs against exchange caps
- Governing Law: Default NY; consider DE if charter-related issues are central
- Survival: Indemnification must expressly survive termination (statute of limitations period recommended)
Related Skills
casemark/medical-records-gap-analysis
tools
VerifiedTrustedCommunity
Audits the complete in-scope medical-record universe in a litigation matter and produces an attorney-facing, Bates-cited analysis of treatment gaps, missing records or providers, baseline coverage, material billing or production mismatches, and complaint evolution. Use when asked to find missing medical records, analyze treatment gaps or first-care timing, identify absent providers, assess whether a production is complete, or prepare a records-request target list. Use medical-record-chronology instead when the primary request is a chronological clinical narrative.
40SKILL.mdUpdated Sep 3, 2026
casemark/private-placement-memo
development
VerifiedTrustedCommunity
Drafts a legally compliant Private Placement Memorandum for Regulation D offerings (Rule 506(b)/506(c)), covering full disclosure framework including risk factors, capitalization, securities terms, use of proceeds, and investor qualification requirements. Enforces SEC anti-fraud compliance under Section 10(b)/Rule 10b-5, blue sky law considerations, and accredited investor verification under Rule 501. Use this skill when drafting PPMs, offering memorandums, Reg D disclosure documents, or private offering circulars for issuers raising capital from sophisticated investors. Also trigger when the user mentions private placement disclosure, offering memorandum, Reg D fundraising, or accredited investor verification. Even if the user just says "PPM" or "draft our offering memo," use this skill.
40SKILL.mdUpdated Apr 17, 2026
casemark/privacy-law-updates
data-ai
VerifiedTrustedCommunity
Generates structured privacy and data protection law briefings across US, EU, UK, and other jurisdictions. Organizes by jurisdiction with compliance deadlines, enforcement actions, and legislative changes. Use when preparing privacy law briefings, compliance updates, regulatory change summaries, or data protection landscape reviews.
40SKILL.mdUpdated Apr 17, 2026
casemark/prior-art-summary
testing
VerifiedTrustedCommunity
Generates structured summaries of prior art references for patent prosecution, validity analysis, and freedom-to-operate assessments. Maps disclosures to claim elements with precise citations. Use when summarizing prior art, analyzing patent landscapes, mapping references to claims, or preparing office action responses.
40SKILL.mdUpdated Apr 17, 2026